臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 50718375 Online Users : 458 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

Administrator

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ou d l"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 21-30 of 103 (11 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-02-08T07:49:40Z	Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti-PD1 in Liver Cancer	Ou D.-L.; SJ TSENG; Kempson I.M.; Hsu C.-L.; Yang P.-C.; Liao Z.-X.
臺大學術典藏	2022-01-24T06:05:32Z	Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer	Hsieh C.-H.; Jian C.-Z.; Lin L.-I.; Low G.-S.; Ou P.-Y.; CHIUN HSU; Ou D.-L.
臺大學術典藏	2022-01-12T07:07:41Z	CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia	Lin T.-C.; HSIN-AN HOU; Chou W.-C.; Ou D.-L.; Yu S.-L.; Tien H.-F.; Lin L.-I.
臺大學術典藏	2022-01-12T07:07:25Z	Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD)	Lu J.-W.; Wang A.-N.; Liao H.-A.; Chen C.-Y.; HSIN-AN HOU; Hu C.-Y.; Tien H.-F.; Ou D.-L.; Lin L.-I.
臺大學術典藏	2022-01-12T07:07:10Z	Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias	Su K.-W.; Ou D.-L.; Fu Y.-H.; Tien H.-F.; HSIN-AN HOU; Lin L.-I.
國立成功大學	2022	Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma	Shao, Y.-Y.;Chen, P.-S.;Lin, Lin L.-I.;Lee, B.-S.;Ling, A.;Cheng, A.-L.;Hsu, C.;Ou, D.-L.
臺大學術典藏	2021-09-15T01:20:53Z	Development of a PD-L1-expressing orthotopic liver cancer model: Implications for immunotherapy for hepatocellular carcinoma	Ou D.-L.; Lin Y.-Y.; CHIA-LANG HSU; Lin Y.-Y.; Chen C.-W.; Yu J.-S.; Miaw S.-C.; Hsu P.-N.; Cheng A.-L.; Hsu C.
臺大學術典藏	2021-09-15T01:20:46Z	Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages	Ou D.-L.; Chen C.-W.; CHIA-LANG HSU; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C.
臺大學術典藏	2021-09-15T01:20:45Z	Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma	CHIA-LANG HSU; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; Jeng Y.-M.; Hsu C.
臺大學術典藏	2021-09-15T01:20:45Z	Enhanced Targeting and Immune Activation of Tumor Microenvironment by Nanomodified Anti-PD1 in Liver Cancer	Ou D.-L.; Tseng S.-J.; Kempson I.M.; CHIA-LANG HSU; Yang P.-C.; Liao Z.-X.

Showing items 21-30 of 103 (11 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page